WALTHAM, Mass.--(BUSINESS WIRE)--NeurAxon, Inc. today announced several scientific presentations by officers and advisors to the Company at the International Symposium on Nitric Oxide and Other Gaseous Neurotransmitters, May 27 – 28, 2010 in Toronto, Ontario. NeurAxon is focused on the discovery and development of next-generation pain therapeutics targeting neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization.
